Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2 英文参考文献.docVIP

下载本文档

0
0
约3.71万字
约 9页
2017-05-12 发布于上海
举报

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2 英文参考文献.doc

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2 英文参考文献

Lapatinib,aDualEGFRandHER2TyrosineKinase Inhibitor,DownregulatesThymidylateSynthaseby InhibitingtheNuclearTranslocationofEGFRandHER2 Hwang-PhillKim1,Young-KwangYoon1,Jin-WonKim2,Sae-WonHan2,Hyung-SeokHur1,JinahPark1, Ju-HeeLee1,Do-YounOh1,2,Seock-AhIm1,2,Yung-JueBang1,2,Tae-YouKim1,2 * 1CancerResearchInstitute,SeoulNationalUniversityCollegeofMedicine,Seoul,Korea,2DepartmentofInternalMedicine,SeoulNationalUniversityCollegeofMedicine, Seoul,Korea Abstract Background:Epidermalgrowthfactorreceptortyrosinekinaseinhibitor(EGFR-TKI)hasbeenshowntoexertasynergistic antitumor effect when combined with

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2 英文参考文献.docVIP